Ironwood Pharmaceuticals Inc (IRWD) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Ironwood Pharmaceuticals inc   (NASDAQ: IRWD)


Ironwood Pharmaceuticals Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Ironwood Pharmaceuticals Inc's ROI in the third quarter of 2026?
Ironwood Pharmaceuticals inc achieved a return on average invested assets (ROI) of 72.05 % in its third quarter of 2026, this is above IRWD's average return on investment of -32.32%.
Ironwood Pharmaceuticals Inc invested over the 12 months ending in its third quarter of 2026 $208 million

ROI fell compared to the second quarter of 2026, despite the net income growth of 16.66% from the second quarter of 2026.

Within the Healthcare sector 19 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 54 to 58.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 13.72 % -22.45 % -53.64 % -40.64 % -17.41 %
Y / Y Net Income Change TTM 424.1 % - - 306.93 % 683.02 %
Investment (TTM) in Millions 256 252 168 155 121
Return On Investment (TTM) 72.05 % 74.67 % 78.56 % 15.95 % 15.63 %
IRWD's Overall Ranking # 58 # 54 # 430 # 320 #
Seq. Investment Change TTM 19.41 % 33.72 % -13.65 % -17.52 % -18.58 %
Seq. Net Income Change TTM 15.21 % 27.1 % 325.43 % -15.87 % -
Net Income (TTM) in Millions 150 130 102 24 29

IRWD Company Profile >> Back to IRWD Roi Comparisons >> See Annual IRWD Return On Investment



Return On Investment IRWD's Ranking
Within: No.
Industry # 8
Sector # 20
Overall # 58

Return On Investment Statistics
High Average Low
83.63 %
-32.32 %
-541.18 %
(Jun 30 2021)   (Mar 31 2024)







Financial Statements
Ironwood Pharmaceuticals Inc's III. Quarter Investments $ 256 Millions IRWD's Balance sheet
Ironwood Pharmaceuticals Inc's III. Quarter Income $ 60 Millions Quarterly IRWD's Income Statement
IRWD's Income by Division See IRWD's Income by Division


IRWD Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 123 283 152 1,049 1,414
Y / Y Investment Growth -56.43 % 85.94 % -85.5 % -25.85 % 179.06 %
Net Income in Millions 24 1 -1,032 175 528
Y / Y Net Income Growth 2629.2 % - - -66.87 % 397.71 %
Annual Return On Investment 19.5 % 0.31 % -678.59 % 16.69 % 37.37 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 19.5 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
IRWD's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for IRWD's Competitors
Subscribers only: Roi for Ironwood Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for IRWD's Customers

Other Ratios
IRWD's Roa IRWD's Inventory Turnover Ratio IRWD's Growth Rates IRWD's Dividend Statistics
IRWD's Profitability Ratios IRWD's Asset Turnover Ratio IRWD's Dividend Growth
IRWD's Roe IRWD's Valuation Ratios IRWD's Financial Strength Ratios IRWD's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Indivior Pharmaceuticals Inc   108.22 %
Exelixis Inc   75.01 %
Ironwood Pharmaceuticals inc   68.68 %
Rigel Pharmaceuticals Inc  68.50 %
Alnylam Pharmaceuticals Inc   63.14 %
Idexx Laboratories Inc  52.51 %
Aurinia Pharmaceuticals Inc   45.04 %
Nurix Therapeutics Inc   44.12 %
Medpace Holdings Inc   41.14 %
Rallybio Corporation  36.04 %
Eli Lilly And Company  32.00 %
Caredx Inc   30.65 %
Zevra Therapeutics Inc   29.88 %
Acadia Pharmaceuticals Inc   26.89 %
Standard Biotools Inc   23.91 %
Iradimed Corporation  22.98 %
Corcept Therapeutics Inc  22.08 %
Resmed Inc   21.10 %
Alector Inc   20.83 %
Chemed Corporation  20.46 %
Halozyme Therapeutics Inc   19.64 %
Pro dex Inc   19.11 %
Dexcom Inc   18.92 %
Illumina Inc   18.74 %
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %

Date modified: 2026-11-08T19:29:38+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.